Leuthold Group, LLC Abbott Laboratories Transaction History

Leuthold Group, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 31, 2023	SELL	$95.06 - $111.52 $116,828 - $137,058	-1,229 Reduced 2.27%	52,802 $5.8 Million
Q3 2022 Oct 31, 2022	SELL	$96.76 - $112.03 $55,830 - $64,641	-577 Reduced 1.06%	54,031 $5.23 Million
Q2 2022 Aug 01, 2022	BUY	$102.07 - $123.37 $954,864 - $1.15 Million	9,355 Added 20.67%	54,608 $5.93 Million
Q1 2022 May 04, 2022	BUY	$114.02 - $139.04 $1.29 Million - $1.57 Million	11,301 Added 33.29%	45,253 $5.36 Million
Q4 2021 Feb 03, 2022	SELL	$115.53 - $141.46 $65,505 - $80,207	-567 Reduced 1.64%	33,952 $4.78 Million
Q3 2021 Nov 15, 2021	BUY	$116.66 - $129.06 $4.03 Million - $4.46 Million	34,519 New	34,519 $4.08 Million

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Leuthold Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Leuthold Group, LLC with notifications on news.